|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Drug Hunter, Inc.
0 Patents (Medical) associated with Drug Hunter, Inc.
Chemical communications (Cambridge, England)
Diversifying chemical space of DNA-encoded libraries: synthesis of 2-oxa-1-azaspiro(bicyclo[3.2.0])heptanes on-DNA via visible light-mediated energy transfer catalysis
Article
Author: Crane, Erika A. ; Levitre, Guillaume ; Matsuo, Bianca ; Li, Longbo ; Molander, Gary A. ; Kim, Saegun ; Shreiber, Scott T. ; Voight, Eric A. ; McClain, Edward J.
Azaspiro[3.3]heptanes are valuable synthetic targets for drug discovery programs.
100 Deals associated with Drug Hunter, Inc.
100 Translational Medicine associated with Drug Hunter, Inc.